EP
ABMD

Eversept Partners’s Abiomed Inc ABMD Stock Holding History

Eversept Partners’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-52,970
Closed -$13M – 83
2022
Q3 		$13M Sell
52,970
-16,327
-24% -$4.41M 1.13% 22
2022
Q2 		$17.2M Buy
+69,297
New +$18.7M 1.22% 26
2019
Q4 		– Sell
-29,950
Closed -$5.33M – 80
2019
Q3 		$5.33M Buy
+29,950
New +$6.47M 1.65% 16
2019
Q2 		– Sell
-27,339
Closed -$7.81M – 71
2019
Q1 		$7.81M Buy
27,339
+13,400
+96% +$4.45M 2.28% 13
2018
Q4 		$4.53M Buy
13,939
+10,520
+308% +$3.65M 2.45% 10
2018
Q3 		$1.54M Sell
3,419
-2,175
-39% -$857K 0.67% 29
2018
Q2 		$2.29M Sell
5,594
-1,500
-21% -$543K 1.05% 23
2018
Q1 		$2.06M Sell
7,094
-1,500
-17% -$380K 0.96% 24
2017
Q4 		$1.61M Buy
+8,594
New +$1.6M 0.93% 27

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $14.7B AUM 42.39% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $65.2B AUM 31.44% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Eversept Partners's ABMD Position: Q4 2022 in Review

Eversept Partners sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 52,970 shares — an estimated $13M sold.

Eversept Partners first reported a position in ABMD in Q4 2017 and held it in 9 quarters. The position peaked at $17.2M in Q2 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Eversept Partners reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Eversept Partners sold 52,970 Abiomed Inc shares in Q4 2022, an estimated $13M.
  • Eversept Partners first reported a position in Abiomed Inc in Q4 2017 and held it in 9 quarters.
  • Eversept Partners's Abiomed Inc position peaked at $17.2M in Q2 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Eversept Partners's 13F filing for Q4 2022, filed 14 Feb 2023.